The treatment of meningitis in infants with co-trimoxazole administered parenterally
Related Experiment Videos
Abstract:
We found that co-trimoxazole had a good clinical and antibacterial effect when given parenterally to infants with infections of the central nervous system. We showed good concentrations in the serum and satisfactory penetrations into the cerebrospinal fluid. In one case, there was a side effect which may have been due to the sulpha or to the solvent. We think that at present the preparation should not be given to very premature babies or to babies with icterus, for the same reasons that we avoid using sulpha preparations in these conditions, but otherwise it may be of great use in difficult cases of meningitis caused by Gram-negative bacteria in infancy.
Insights
Co-trimoxazole demonstrated effective clinical and antibacterial outcomes in infants with central nervous system infections. It achieved good serum concentrations and cerebrospinal fluid penetration, with cautious use advised for premature infants or those with icterus.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Central nervous system (CNS) infections in infants pose significant treatment challenges.
- Parenteral co-trimoxazole offers a potential therapeutic option for severe bacterial infections.